Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women
NCT00440375Phase 4Completed
- Sponsor
- Baskent University
- Start
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by Baskent University. Started Jun 2005; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00440375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440375.